AMENDED AND RESTATED EXECUTIVE AGREEMENTExecutive Agreement • May 26th, 2017 • ContraVir Pharmaceuticals, Inc. • Pharmaceutical preparations • New Jersey
Contract Type FiledMay 26th, 2017 Company Industry JurisdictionThis Amended and Restated Executive Agreement (the “Agreement”) is made and entered into effective as of May 25, 2017 (the “Effective Date”), by and between James Sapirstein (the “Executive”) and ContraVir Pharmaceuticals, Inc., a Delaware corporation (the “Company”).